Media

Novartis Financial Results – Q2 2019

Novartis announced the company’s financial results for the second quarter and first half of 2019.

Video - Novartis Financial Results

Our Executive Team talks about innovation highlights from the second quarter of 2019.

Watch video

Latest media releases

Jul 19, 2019

Novartis key multiple sclerosis product Gilenya® approved in China
Jul 18, 2019

Novartis delivers strong sales, double digit core operating income growth and launches Zolgensma and Piqray in second quarter; sales and profit guidance increased
Jul 16, 2019

FDA accepts file and accelerates review of Novartis sickle cell disease medicine crizanlizumab (SEG101)
Jul 11, 2019

Novartis, Amgen and Banner Alzheimer's Institute discontinue clinical program with BACE inhibitor CNP520 for Alzheimer's prevention

News archive

Subscribe to media releases

Resources

Media Library

Browse and download multimedia resources including images, videos, infographics and more.

Visit the Media Library

Novartis Annual Review 2018

The Annual Review, our new corporate report, explains who we are and what we do, and highlights our progress against the company’s five strategic priorities in 2018.

Read the Annual Review

A healthcare professional speaks to a patient

Corporate Responsibility

Learn more about our Corporate Responsibility strategy and access resources including the annual Novartis in Society Report

Learn more

Corporate Fact Sheets

The fact sheets provide a comprehensive overview of Novartis overall as well as our divisions and our research organization. It also outlines our commitment to associates and to corporate responsibility.

View Fact Sheets

Social media